“Giving attendees the means needed to mitigate risk and help projects run smoother is essential,” Track 3 Chair Robyn Lim, Ph.D., Senior Science Advisor, Office of Legislative and Regulatory Modernization, Health Products and Food Branch, Health Canada. “Additionally feedback from invited local patient participants with serious chronic conditions will enrich the discussions and provide valuable insights to improve the current methods as well raise awareness across the decision-making health community about the latest trends and progressing strategies in drug development and regulation.”
Register for DIA Canadian Annual Meeting 2012: Evolutions in Risk Thinking here.

About DIA

DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. www.diahome.org. Follow DIA on Facebook, Twitter, LinkedIn, Flickr and YouTube.
Stay updated on hot topic news at #druginfoassn on Twitter.